A randomized controlled trial comparing low molecular weight heparin and aspirin to aspirin alone in women with unexplained recurrent pregnancy loss.

Trial Profile

A randomized controlled trial comparing low molecular weight heparin and aspirin to aspirin alone in women with unexplained recurrent pregnancy loss.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 23 Oct 2009

At a glance

  • Drugs Aspirin; Dalteparin sodium
  • Indications Abortion; Fetal death; Pregnancy; Thrombosis
  • Focus Therapeutic Use
  • Acronyms HepASA
  • Most Recent Events

    • 24 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top